Skip to main content
Sunita (Dwivedy) Nasta, MD, Oncology, Philadelphia, PA, Hospital of the University of Pennsylvania

SunitaDwivedy(Dwivedy)NastaMDFACP

Oncology • Philadelphia, PA

Hematologic Oncology

Professor of Clinical Medicine

Join to view full profile

Dr. Nasta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nasta's full profile

Already have an account?

  • Office

    3400 Civic Center Blvd
    Fl 12South PCAM
    Philadelphia, PA 19104
    Phone+1 215-662-3933
    Fax+1 215-615-5887
  • Is this information wrong?

Summary

  • Dr. Sunita Nasta is an oncologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania. She received her medical degree from Virginia Commonwealth University School of Medicine with residency training at Baylor Collegand has been in practice 22 years. She specializes in hematologic oncology and is experienced in non-hodgkin lymphoma, hematologic oncology, t-cell lymphomas, hodgkin's lymphoma, and clinical research.

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 1995 - 1998
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 1995
  • Stanford University
    Stanford UniversityBS, Micrbiology/Immunology, Research honors, 1987 - 1991

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2001 - 2024
  • TX State Medical License
    TX State Medical License 1997 - 2003
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-Exposure SARS-CoV-2 Prophylaxis Among Health Care Workers  
    Matthew C Hyman, Ian Frank, Scott E Hensley, Saar Gill, Dan T Vogl, Ivan Maillard, Daria V Babushok, Alexander C Huang, Sunita D Nasta, Jennifer C Walsh, Michael C Mil..., JAMA Internal Medicine
  • International, Evidence-Based Consensus Treatment Guidelines for Idiopathic Multicentric Castleman Disease  
    Aaron Goodman, Corey Casper, Sudipto Mukherjee, Peter Voorhees, Angela Dispenzieri, David C Fajgenbaum, Amy Chadburn, Razelle Kurzrock, Raj Jayanthan, Sunita Nasta, Th..., Blood
  • Non-Viral RNA Chimeric Antigen Receptor Modified T Cells in Patients with Hodgkin Lymphoma  
    Stephan A Grupp, Sunita Dwivedy Nasta, Susan R Rheingold, Daniel J Landsburg, Carl H June, Jakub Svoboda, Stephen J Schuster, Saar I Gill, David L Porter, Bruce L Levine, Blood

Abstracts/Posters

  • Identification and Validation of Predictive Biomarkers to CD19- and BCMA-Specific CAR T-Cell Responses in CAR T-Cell Precursors
    Sunita D Nasta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Mu...
    Sunita Dwivedy Nasta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Use of Bendamustine for Lymphodepletion before Tisagenlecleucel (anti-CD19 CAR T cells) for Aggressive B-Cell Lymphomas
    Sunita Dwivedy Nasta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • A Characterization of Bridging Therapies Leading up to Commercial CAR T-Cell Therapy 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Hospitalization Patterns with Commercial CAR T-Cell Therapy: A Single Institution Experience 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Clinical Outcomes of Venetoclax Therapy in Patients with Relapsed/Refractory (r/r) Non Hodgkin Lymphomas (NHL) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • OncLive® Presents State of the Science Summit™ on the Treatment of Hematologic Malignancies
    OncLive® Presents State of the Science Summit™ on the Treatment of Hematologic MalignanciesSeptember 10th, 2019
  • Expert Emphasizes Appropriate Diagnosis, Staging of T-cell Lymphomas
    Expert Emphasizes Appropriate Diagnosis, Staging of T-cell LymphomasNovember 30th, 2017

Committees

  • Chair, Clinical Trials Scientific Monitoring Committee 2015 - Present

Professional Memberships

Hospital Affiliations

Dr. Sunita Nasta, Dr. Sunita Nasta, MD, Dr. S Nasta, Dr. Sunita Dwivedy Nasta